Skip to main content
. 2008 Sep 10;467(6):1599–1604. doi: 10.1007/s11999-008-0483-1

Table 1.

Pathologic diagnoses and blood loss volumes of 173 patients with sacral tumors

Pathologic diagnosis Number of patients Blood loss volume (mL)
Minimum Maximum Mean Standard deviation
Benign tumor 69 250 8020 2826.59 1880.61
    Neurofibroma/schwannoma 20 700 7700 3094.50 1793.45
    Teratoma 6 290 1750 898.33 618.40
    Aneurysmal bone cyst 1 350
    Giant cell tumor 27 350 8020 3741.85 1809.49
    Other benign tumor 15 250 4200 1758.33 1274.10
Low-grade malignant tumor 31 500 6000 2597.42 1443.30
    Chordoma 31 500 6000 2597.42 1443.30
High-grade malignant tumor 26 700 9900 3533.46 2198.86
    Neurofibrosarcoma 7 2350 9900 4874.29 3103.67
    Chondrosarcoma 6 1150 7170 3486.67 2087.84
    Osteosarcoma 4 700 4720 2942.50 2006.46
    Ewing’s sarcoma 4 1400 4310.00 2452.50 1278.29
    Liposarcoma 3 3400 4250.00 3733.33 453.67
    Malignant fibrous histiocytoma 2 1500.00 2550.00 2025.00 742.46
Metastatic tumor 47 500 8700 2939.68 1793.44
    Renal carcinoma 5 1350.00 6620.00 4208.00 2338.88
    Multiple myeloma 4 1150.00 4730.00 3270.00 1679.66
    Hepatocarcinoma 1 2600
    Thyroid carcinoma 1 3260
    Other metastatic tumors 36 500 8700 2727.36 1750.84